Metabolomics at the tumor microenvironment interface: Decoding cellular conversations

Area of Science:

• Oncology and Molecular Biology

Background:

• Cancer heterogeneity poses a significant challenge to effective treatments.
• Altered cellular energetics is a key hallmark of cancer, impacting tumor growth and drug resistance.
• Tumor metabolic profiling reveals heterogeneity, suggesting personalized combination therapies with metabolic interventions can improve patient outcomes.

Purpose of the Study:

• To review how altered metabolic pathways drive cancer progression and drug resistance.
• To explore the capabilities of spatial metabolomics technologies.
• To discuss the integration of spatial metabolomics into clinical practice for improved patient outcomes.

Main Methods:

• Review of current literature on cancer metabolism and spatial metabolomics.
• Analysis of how metabolite distribution within the tumor microenvironment influences cancer biology.
• Examination of recent advancements in spatial metabolomics, including subcellular resolution.

Main Results:

• Metabolomic studies are identifying novel biomarkers and therapeutic targets.
• Spatial metabolomics enables a deeper understanding of metabolite distribution and its role in cancer.
• Techniques now allow metabolite mapping at the subcellular level.

Conclusions:

• Understanding metabolic heterogeneity is crucial for developing effective cancer therapies.
• Spatial metabolomics offers potential for improved precision medicine, earlier diagnosis, and intraoperative tumor margin identification.
• Integrating spatial metabolomics into clinical practice could significantly enhance patient outcomes.